文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

四种腺嘌呤相关 RNA 修饰写入器介导的分子亚型有助于预测膀胱癌的临床结局和治疗选择。

Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer.

机构信息

Department of gynaecology, Shengjing Hospital of China Medical University, Shenyang, China.

Department of Ultrasound, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, China.

出版信息

Front Immunol. 2023 Aug 11;14:1152806. doi: 10.3389/fimmu.2023.1152806. eCollection 2023.


DOI:10.3389/fimmu.2023.1152806
PMID:37638051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10450768/
Abstract

RATIONALE: RNA modifications, containing m6A, m1A, alternative polyadenylation and adenosine-to-inosine RNA editing, involve in critical cancerous immunity and cancerous processes. However, the functional roles of RNA modification writers in bladder cancer (BLCA) are largely unknown. METHODS: In this study, unsupervised clustering was used to identify novel RNA modification writers -mediated molecular subtypes in BLCA. A corresponding quantitative indicator called WriterScore was developed using univariate Cox and Least absolute shrinkage and selection operator (LASSO) analysis. Then, we systematically analyzed the correlation between RNA modification writer-related clusters (WriterScore) and immunological characteristics, classical molecular subtypes, clinicopathologic features and treatment options in BLCA. Finally, we validated the WriterScore in multiple other external BLCA datasets, clinical sample dataset in Shengjing Hospital and pancancer. RESULTS: Two RNA modification writer-related clusters and three DEGclusters were obtained. These RNA modification writer-related clusters (WriterScore) were strongly associated with immunological characteristics, classical molecular subtypes, clinicopathologic features of BLCA. Moreover, WriterScore can properly predict the clinical outcomes and immunotherapy of BLCA patients. CONCLUSION: Our study systematically investigated the role of RNA modification writers and developed a significant WriterScore to guide several treatment options in BLCA, which might bring some potential benefits for BLCA patients.

摘要

背景:RNA 修饰(包含 m6A、m1A、可变多聚腺苷酸化和腺苷到肌苷 RNA 编辑)参与了关键的癌症免疫和癌症过程。然而,RNA 修饰写入器在膀胱癌(BLCA)中的功能作用在很大程度上是未知的。

方法:在这项研究中,使用无监督聚类来鉴定 BLCA 中新型 RNA 修饰写入器介导的分子亚型。使用单变量 Cox 和最小绝对收缩和选择算子(LASSO)分析开发了一个相应的定量指标,称为 WriterScore。然后,我们系统地分析了 RNA 修饰写入器相关簇(WriterScore)与 BLCA 中的免疫特征、经典分子亚型、临床病理特征和治疗选择之间的相关性。最后,我们在多个其他外部 BLCA 数据集、盛景医院和泛癌临床样本数据集中验证了 WriterScore。

结果:获得了两个 RNA 修饰写入器相关簇和三个 DEG 簇。这些 RNA 修饰写入器相关簇(WriterScore)与 BLCA 的免疫特征、经典分子亚型、临床病理特征密切相关。此外,WriterScore 可以正确预测 BLCA 患者的临床结局和免疫治疗。

结论:我们的研究系统地研究了 RNA 修饰写入器的作用,并开发了一个有意义的 WriterScore 来指导 BLCA 的几种治疗选择,这可能为 BLCA 患者带来一些潜在的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/d6f91547fd14/fimmu-14-1152806-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/efe49335e140/fimmu-14-1152806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/19c9763fa603/fimmu-14-1152806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/35e95918655e/fimmu-14-1152806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/5f99ffad573f/fimmu-14-1152806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/f2c66cfbe85e/fimmu-14-1152806-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/d6f91547fd14/fimmu-14-1152806-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/efe49335e140/fimmu-14-1152806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/19c9763fa603/fimmu-14-1152806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/35e95918655e/fimmu-14-1152806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/5f99ffad573f/fimmu-14-1152806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/f2c66cfbe85e/fimmu-14-1152806-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a16/10450768/d6f91547fd14/fimmu-14-1152806-g006.jpg

相似文献

[1]
Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer.

Front Immunol. 2023

[2]
Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.

Front Immunol. 2021

[3]
RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.

EBioMedicine. 2022-10

[4]
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.

BMC Cancer. 2021-11-21

[5]
5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer.

BMC Med. 2021-11-26

[6]
Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.

Mol Cancer. 2021-2-8

[7]
Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.

Front Immunol. 2022

[8]
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.

J Transl Med. 2023-3-27

[9]
Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer.

Front Genet. 2023-4-12

[10]
Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.

Front Cell Dev Biol. 2022-1-26

引用本文的文献

[1]
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.

Signal Transduct Target Ther. 2025-7-18

[2]
RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond.

Exp Hematol Oncol. 2025-4-2

[3]
Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.

BMC Cancer. 2024-2-14

[4]
Research progress of N1-methyladenosine RNA modification in cancer.

Cell Commun Signal. 2024-1-30

本文引用的文献

[1]
Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer.

Dis Markers. 2022

[2]
Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer.

Ann Transl Med. 2022-11

[3]
The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective.

Front Immunol. 2022

[4]
RNA modifications: importance in immune cell biology and related diseases.

Signal Transduct Target Ther. 2022-9-22

[5]
Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.

Hum Genomics. 2022-4-22

[6]
PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration.

J Oncol. 2022-2-24

[7]
Cancer statistics, 2022.

CA Cancer J Clin. 2022-1

[8]
5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer.

BMC Med. 2021-11-26

[9]
Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives.

Cancers (Basel). 2021-8-31

[10]
Integrated analyses of mA regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancer.

Oncoimmunology. 2021-6-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索